Clinical characteristics and treatment responses of patients who developed tuberculosis following use of a tumor necrosis factor-α inhibitor

Lignende værker

• Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy
  af: Suh, Young Sun, et al.
  Udgivet: (2014)
• Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection
  af: Lee, Eun Hye, et al.
  Udgivet: (2017)
• Tumour necrosis factor-α inhibitors and the reactivation of latent tuberculosis infection
  af: Long, Richard, et al.
  Udgivet: (2003)
• Incidences of Serious Infections and Tuberculosis among Patients Receiving Anti-Tumor Necrosis Factor-α Therapy
  af: Yoo, In Kyung, et al.
  Udgivet: (2014)
• Erratum: Correction of Notes. Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy
  af: Suh, Young Sun, et al.
  Udgivet: (2014)